KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,224,000 | -76.3% | 836,515 | -83.5% | 0.00% | -77.8% |
| Q3 2015 | $17,821,000 | -72.8% | 5,062,743 | -23.0% | 0.01% | -70.0% |
| Q2 2015 | $65,618,000 | -23.4% | 6,574,952 | -2.3% | 0.03% | -23.1% |
| Q1 2015 | $85,655,000 | +13.3% | 6,728,594 | +25.9% | 0.04% | +14.7% |
| Q4 2014 | $75,625,000 | +12.0% | 5,344,500 | +8.9% | 0.03% | +9.7% |
| Q3 2014 | $67,503,000 | +48.9% | 4,909,289 | +66.6% | 0.03% | +55.0% |
| Q2 2014 | $45,323,000 | -12.6% | 2,946,900 | -3.1% | 0.02% | -16.7% |
| Q1 2014 | $51,842,000 | +67.8% | 3,042,400 | +27.5% | 0.02% | +60.0% |
| Q4 2013 | $30,890,000 | +10.4% | 2,385,300 | -13.9% | 0.02% | 0.0% |
| Q3 2013 | $27,976,000 | +66.7% | 2,769,900 | +23.3% | 0.02% | +50.0% |
| Q2 2013 | $16,787,000 | – | 2,247,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |